The escalating prevalence of obesity worldwide poses a significant challenge to healthcare professionals. This complex, multifaceted condition requires a comprehensive, integrated approach to management, encompassing lifestyle modification, pharmacotherapy, and potentially, surgery.
The cornerstone of obesity management is lifestyle intervention, which incorporates dietary changes, physical activity, and behavior modification. A personalized approach, tailored to the patient's preferences and capabilities, is crucial for the success of this intervention. Multidisciplinary teams involving dietitians, physical therapists, and psychologists can provide valuable support.
Pharmacotherapy is an adjunct to lifestyle intervention and is indicated in patients with a BMI of 30 or above, or 27 and above in the presence of comorbidities. Several agents, including orlistat, liraglutide, and bupropion-naltrexone, have been approved for long-term use. These drugs should be used judiciously, considering their side-effect profiles and contraindications.
Bariatric surgery is considered in patients with severe obesity (BMI >40) or moderate obesity (BMI >35) with associated comorbidities. It offers substantial and sustained weight loss, along with improvements in obesity-related conditions. However, it carries surgical risks and necessitates lifelong medical follow-up and nutritional supplementation.
Emerging therapies in obesity management include novel pharmacological agents targeting various aspects of energy homeostasis, and minimally invasive procedures such as endoscopic sleeve gastroplasty. While promising, these therapies require further investigation to establish their safety and efficacy.
Effective obesity management demands a comprehensive, patient-centered strategy, encompassing lifestyle intervention, pharmacotherapy, and, where appropriate, surgery. Keeping abreast of emerging therapies is crucial to expanding our arsenal in the battle against this global health issue. The ultimate goal is to improve the quality of life and longevity of our patients.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation